These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 23154550)

  • 1. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
    Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
    J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
    Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
    J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
    Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
    Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
    Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
    Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
    Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD163
    Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
    Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
    Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
    Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.
    Qiu X; Chen D; Liu Y; Duan S; Zhang F; Zhang Y; Li F; Chen C; Chen Y
    Thorac Cancer; 2019 Feb; 10(2):256-267. PubMed ID: 30605235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma.
    Sun Y; Xu S
    Biomed Res Int; 2018; 2018():8459193. PubMed ID: 29850577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating CD14+CD204+ cells predict postoperative recurrence in non-small-cell lung cancer patients.
    Maeda R; Ishii G; Neri S; Aoyagi K; Haga H; Sasaki H; Nagai K; Ochiai A
    J Thorac Oncol; 2014 Feb; 9(2):179-88. PubMed ID: 24419414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
    Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
    BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
    Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Software-assisted morphometric and phenotype analyses of human peripheral blood monocyte-derived macrophages induced by a microenvironment model of human esophageal squamous cell carcinoma.
    Nishio M; Urakawa N; Shigeoka M; Takase N; Ichihara Y; Arai N; Koma Y; Yokozaki H
    Pathol Int; 2016 Feb; 66(2):83-93. PubMed ID: 26778807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.
    Sekihara K; Hishida T; Ikemura S; Saruwatari K; Morise M; Kuwata T; Fujii S; Kojima M; Ochiai A; Funai K; Aokage K; Yoshida J; Tsuboi M; Ishii G
    J Cancer Res Clin Oncol; 2016 May; 142(5):905-12. PubMed ID: 26696594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the number of viable tumor cells and immune cells in the tumor microenvironment in non-small cell lung cancer after induction therapy.
    Hoshino H; Aokage K; Miyoshi T; Tane K; Kojima M; Sugano M; Kuwata T; Ochiai A; Suzuki K; Tsuboi M; Ishii G
    Pathol Int; 2021 Aug; 71(8):512-520. PubMed ID: 34115921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
    Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of sonic hedgehog signaling pathway components on non-small-cell lung cancer progression and clinical outcome.
    Hwang J; Kang MH; Yoo YA; Quan YH; Kim HK; Oh SC; Choi YH
    World J Surg Oncol; 2014 Aug; 12():268. PubMed ID: 25141859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.
    Imayama N; Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Seki S; Fujita S; Ikeda T; Umeda M
    Pathol Oncol Res; 2015 Jul; 21(3):783-91. PubMed ID: 25573594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD206
    Haque ASMR; Moriyama M; Kubota K; Ishiguro N; Sakamoto M; Chinju A; Mochizuki K; Sakamoto T; Kaneko N; Munemura R; Maehara T; Tanaka A; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
    Sci Rep; 2019 Oct; 9(1):14611. PubMed ID: 31601953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.